why choose us

300×250 Ad Slot

Research Article: Utilization of tissue-free minimal residual disease testing in colorectal cancer patients from Asia and Middle East

Date Published: 2024-09-20

Abstract:
Introduction: The presence of minimal residual disease (MRD) after curative-intent surgery for early-stage cancers is associated with disease recurrence. Circulating tumour deoxyribonucleic acid (ctDNA) has emerged as a promising biomarker for MRD assessment in patients with colorectal cancer (CRC) who have undergone surgery or completed adjuvant therapy. MRD tests are already available for use in clinics; however, treatment decisions following MRD results obtained in routine practice are infrequently described.

No summary available.

300×250 Ad Slot